DK377589A - Flerlagsplaster - Google Patents

Flerlagsplaster Download PDF

Info

Publication number
DK377589A
DK377589A DK377589A DK377589A DK377589A DK 377589 A DK377589 A DK 377589A DK 377589 A DK377589 A DK 377589A DK 377589 A DK377589 A DK 377589A DK 377589 A DK377589 A DK 377589A
Authority
DK
Denmark
Prior art keywords
optionally
layer
reservoir
active substance
active substances
Prior art date
Application number
DK377589A
Other languages
English (en)
Other versions
DK377589D0 (da
Inventor
Joel Sinnreich
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK377589D0 publication Critical patent/DK377589D0/da
Publication of DK377589A publication Critical patent/DK377589A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
DK377589A 1988-08-02 1989-08-01 Flerlagsplaster DK377589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH292088 1988-08-02

Publications (2)

Publication Number Publication Date
DK377589D0 DK377589D0 (da) 1989-08-01
DK377589A true DK377589A (da) 1990-02-03

Family

ID=4244591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK377589A DK377589A (da) 1988-08-02 1989-08-01 Flerlagsplaster

Country Status (16)

Country Link
US (1) US5032403A (da)
EP (1) EP0356382B1 (da)
JP (1) JPH0278615A (da)
KR (1) KR900002765A (da)
AT (1) ATE101511T1 (da)
AU (1) AU618114B2 (da)
CA (1) CA1337270C (da)
DE (1) DE58906975D1 (da)
DK (1) DK377589A (da)
ES (1) ES2062093T3 (da)
IE (1) IE63498B1 (da)
IL (1) IL91123A (da)
NZ (1) NZ230137A (da)
PH (1) PH27157A (da)
PT (1) PT91327B (da)
ZA (1) ZA895858B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3939703C2 (de) * 1989-12-01 1998-07-02 Boehringer Ingelheim Kg Verbesserte transdermale Applikation von pharmakologisch aktiven Verbindungen
JP3046346B2 (ja) * 1990-03-12 2000-05-29 昭和電工株式会社 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
KR930007445A (ko) * 1991-10-23 1993-05-20 원본미기재 국소 적용 배합물의 침투 증가방법
US5246705A (en) * 1992-04-08 1993-09-21 Cygnus Therapeutic System Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
US5405614A (en) * 1992-04-08 1995-04-11 International Medical Associates, Inc. Electronic transdermal drug delivery system
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
DE4224325C1 (de) * 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
CA2104046C (en) * 1992-10-05 1998-09-15 Yen-Lane Chen Adhesive compositions, wound dressings and methods
ATE202476T1 (de) * 1992-12-31 2001-07-15 Sunkyong Ind Ltd Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
AU6491494A (en) * 1993-04-07 1994-10-24 Rexham Industries Corp. Method of coating microporous membranes and resulting products
DE4341572C1 (de) * 1993-12-07 1995-06-22 Univ Dresden Tech Zahnriemengetriebe
US5612382A (en) * 1994-07-15 1997-03-18 Frances B. Fike Composition for percutaneous absorption of pharmaceutically active ingredients
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
AU3512595A (en) * 1994-09-13 1996-03-29 Magainin Pharmaceuticals, Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
KR100375474B1 (ko) 1994-10-28 2003-05-17 킴벌리-클라크 월드와이드, 인크. 자체 접착성 흡수용품
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
CN1232389A (zh) * 1996-10-04 1999-10-20 崎玉第一制药株式会社 贴剂
DE19804604A1 (de) * 1998-02-06 1999-08-12 Beiersdorf Ag Vorrichtung zur Freigabe von Stoffen
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
DE19908787A1 (de) * 1999-03-01 2000-09-14 Labtec Gmbh Transdermale Applikation von ß2-Sympathomimetika zur Behandlung obstruktiver Atemwegserkrankungen
DE19913732A1 (de) * 1999-03-26 2000-09-28 Lohmann Therapie Syst Lts Nikotin-TTS mit einem Zusatz von Monoterpenketonen
GB9917290D0 (en) * 1999-07-22 1999-09-22 Glaxo Wellcome Spa Pharmaceutical composition
DE19949202A1 (de) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
DE10027258C1 (de) * 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
DE10056011A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur insbesondere transdermalen Verabreichung ätherischer Öle
DE10136784A1 (de) * 2001-07-27 2003-02-20 Lohmann Therapie Syst Lts Darreichungsformen mit wirkstoffhaltigen Partikeln, zur Anwendung auf der Haut oder Schleimhaut
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
JP5048324B2 (ja) * 2003-04-30 2012-10-17 パーデュー、ファーマ、リミテッド、パートナーシップ 活性物質要素および該活性物質レイヤーの遠位に副作用物質要素を含む耐タンパー性経皮剤形
GB0403808D0 (en) * 2004-02-20 2004-03-24 Bioprogress Technology Ltd Films for use as dosage forms
US20060079513A1 (en) * 2004-10-13 2006-04-13 Preston David M Methods and compositions including methscopolamine nitrate
US20060079514A1 (en) * 2004-10-13 2006-04-13 Victory Pharma Incorporated Methods and compositions including methscopolamine bromide
DE102004059674B4 (de) * 2004-12-10 2010-05-06 Acino Ag Transdermales System zur Abgabe von Scopolamin
US20060182819A1 (en) * 2005-02-17 2006-08-17 Ough Yon D Soap scent patch and treatment for muscle spasm and pain
US20170273974A1 (en) * 2016-03-24 2017-09-28 Medrx Co., Ltd Patch preparations with misuse prevention features
DE102018118507A1 (de) * 2018-07-31 2020-02-06 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440770A (en) * 1980-07-28 1984-04-03 Mochida Seiyaku Kabushiki Kaisha Diuretic, hypotensive and antiedemic quinoline oximes
US4560553A (en) * 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
DE3344691A1 (de) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen Wirkstoffabgasesysteme
DE3347278A1 (de) * 1983-12-28 1985-07-11 Bayer Ag, 5090 Leverkusen Wirkstoffabgabesysteme
DE3423328A1 (de) * 1984-06-23 1986-01-02 Beiersdorf Ag, 2000 Hamburg Selbstklebendes pflaster
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
DE3518707A1 (de) * 1985-05-24 1986-11-27 Beiersdorf Ag, 2000 Hamburg Nitro-pflaster
CH674618A5 (da) * 1987-04-02 1990-06-29 Ciba Geigy Ag
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems

Also Published As

Publication number Publication date
IE892488L (en) 1990-02-02
AU3912089A (en) 1990-02-08
AU618114B2 (en) 1991-12-12
DE58906975D1 (de) 1994-03-24
IE63498B1 (en) 1995-05-03
ES2062093T3 (es) 1994-12-16
ZA895858B (en) 1990-03-28
NZ230137A (en) 1990-10-26
US5032403A (en) 1991-07-16
CA1337270C (en) 1995-10-10
PH27157A (en) 1993-04-02
IL91123A0 (en) 1990-03-19
IL91123A (en) 1994-08-26
DK377589D0 (da) 1989-08-01
PT91327B (pt) 1995-07-06
ATE101511T1 (de) 1994-03-15
EP0356382B1 (de) 1994-02-16
PT91327A (pt) 1990-03-08
EP0356382A2 (de) 1990-02-28
EP0356382A3 (de) 1991-01-09
JPH0278615A (ja) 1990-03-19
KR900002765A (ko) 1990-03-23

Similar Documents

Publication Publication Date Title
ATE101511T1 (de) Mehrschichtiges pflaster.
US4060084A (en) Method and therapeutic system for providing chemotherapy transdermally
US4379454A (en) Dosage for coadministering drug and percutaneous absorption enhancer
ATE188866T1 (de) Transdermales arzneimittelverabreichungssystem
JP3011459B2 (ja) 皮膚透過において制御された時間変化で薬剤を経皮的に投与するためのデバイス
PT90322A (pt) Sistemas monoliticos transdermicos, contendo eucaliptol
DE69531488D1 (de) Medikament enthaltende, adhesive, zusammenbaubare, transdermale abgabevorrichtung
KR890007761A (ko) 피부 또는 점막에 유효약제의 투여장치
HUP0303386A2 (hu) Transzdermális terápiás rendszer abszorbeálószereket és csatornaképzőket tartalmazó hatóanyag-áthatlan fedőbevonata vagy lehúzható védőrétege
DE69414502D1 (de) Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen
DE50112720D1 (de) Transdermales therapeutisches system mit hochdispersem siliziumdioxid
NO332084B1 (no) Transparent innretning for transdermal administrasjon av nikotin
KR870007701A (ko) 불연속 패턴 접착층을 갖는 피부 및 경피용 패치
RU2246937C2 (ru) Система для чрескожного введения никотина
MXPA01006199A (en) Transparent transdermal nicotine delivery devices
NZ245057A (en) Device for administering drug transdermally comprising a reservoir containing a drug and two solvents with a means for controlling the proportion of each solvent in the reservoir in order to control the drug flux

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment